Samples for study ST000502
Species: Homo sapiens (Factor headings shown in green)
| mb_sample_id | Subject name | Sample name | Time(weeks) |
|---|---|---|---|
| SA026115 | - | 4_1 | 4 | Treatment:Control |
| SA026110 | - | 4_11 | 4 | Treatment:Control |
| SA026116 | - | 4_12 | 4 | Treatment:Control |
| SA026120 | - | 4_15 | 4 | Treatment:Control |
| SA026119 | - | 4_20 | 4 | Treatment:Control |
| SA026112 | - | 4_21 | 4 | Treatment:Control |
| SA026105 | - | 4_22 | 4 | Treatment:Control |
| SA026103 | - | 4_24 | 4 | Treatment:Control |
| SA026101 | - | 4_26 | 4 | Treatment:Control |
| SA026100 | - | 4_28 | 4 | Treatment:Control |
| SA026099 | - | 4_29 | 4 | Treatment:Control |
| SA026108 | - | 4_34 | 4 | Treatment:Control |
| SA026107 | - | 4_35 | 4 | Treatment:Control |
| SA026106 | - | 4_40 | 4 | Treatment:Control |
| SA026117 | - | 4_42 | 4 | Treatment:Control |
| SA026104 | - | 4_46 | 4 | Treatment:Control |
| SA026109 | - | 4_49 | 4 | Treatment:Control |
| SA026102 | - | 4_51 | 4 | Treatment:Control |
| SA026118 | - | 4_54 | 4 | Treatment:Control |
| SA026114 | - | 4_58 | 4 | Treatment:Control |
| SA026113 | - | 4_7 | 4 | Treatment:Control |
| SA026111 | - | 4_8 | 4 | Treatment:Control |
| SA026137 | - | 4_10 | 4 | Treatment:GLP-1 analogue |
| SA026132 | - | 4_14 | 4 | Treatment:GLP-1 analogue |
| SA026130 | - | 4_17 | 4 | Treatment:GLP-1 analogue |
| SA026135 | - | 4_2 | 4 | Treatment:GLP-1 analogue |
| SA026131 | - | 4_23 | 4 | Treatment:GLP-1 analogue |
| SA026136 | - | 4_25 | 4 | Treatment:GLP-1 analogue |
| SA026138 | - | 4_27 | 4 | Treatment:GLP-1 analogue |
| SA026142 | - | 4_30 | 4 | Treatment:GLP-1 analogue |
| SA026143 | - | 4_31 | 4 | Treatment:GLP-1 analogue |
| SA026144 | - | 4_33 | 4 | Treatment:GLP-1 analogue |
| SA026141 | - | 4_36 | 4 | Treatment:GLP-1 analogue |
| SA026140 | - | 4_37 | 4 | Treatment:GLP-1 analogue |
| SA026139 | - | 4_38 | 4 | Treatment:GLP-1 analogue |
| SA026134 | - | 4_39 | 4 | Treatment:GLP-1 analogue |
| SA026123 | - | 4_43 | 4 | Treatment:GLP-1 analogue |
| SA026121 | - | 4_44 | 4 | Treatment:GLP-1 analogue |
| SA026124 | - | 4_45 | 4 | Treatment:GLP-1 analogue |
| SA026129 | - | 4_47 | 4 | Treatment:GLP-1 analogue |
| SA026127 | - | 4_48 | 4 | Treatment:GLP-1 analogue |
| SA026133 | - | 4_5 | 4 | Treatment:GLP-1 analogue |
| SA026126 | - | 4_50 | 4 | Treatment:GLP-1 analogue |
| SA026122 | - | 4_52 | 4 | Treatment:GLP-1 analogue |
| SA026125 | - | 4_53 | 4 | Treatment:GLP-1 analogue |
| SA026128 | - | 4_57 | 4 | Treatment:GLP-1 analogue |
| SA026159 | - | 52_1 | 52 | Treatment:Control |
| SA026164 | - | 52_11 | 52 | Treatment:Control |
| SA026163 | - | 52_12 | 52 | Treatment:Control |
| SA026148 | - | 52_15 | 52 | Treatment:Control |
| SA026154 | - | 52_20 | 52 | Treatment:Control |
| SA026153 | - | 52_21 | 52 | Treatment:Control |
| SA026152 | - | 52_22 | 52 | Treatment:Control |
| SA026157 | - | 52_26 | 52 | Treatment:Control |
| SA026149 | - | 52_28 | 52 | Treatment:Control |
| SA026145 | - | 52_29 | 52 | Treatment:Control |
| SA026158 | - | 52_3 | 52 | Treatment:Control |
| SA026150 | - | 52_34 | 52 | Treatment:Control |
| SA026162 | - | 52_40 | 52 | Treatment:Control |
| SA026147 | - | 52_41 | 52 | Treatment:Control |
| SA026151 | - | 52_42 | 52 | Treatment:Control |
| SA026146 | - | 52_46 | 52 | Treatment:Control |
| SA026155 | - | 52_58 | 52 | Treatment:Control |
| SA026156 | - | 52_6 | 52 | Treatment:Control |
| SA026160 | - | 52_7 | 52 | Treatment:Control |
| SA026161 | - | 52_8 | 52 | Treatment:Control |
| SA026177 | - | 52_10 | 52 | Treatment:GLP-1 analogue |
| SA026175 | - | 52_14 | 52 | Treatment:GLP-1 analogue |
| SA026176 | - | 52_16 | 52 | Treatment:GLP-1 analogue |
| SA026181 | - | 52_17 | 52 | Treatment:GLP-1 analogue |
| SA026174 | - | 52_18 | 52 | Treatment:GLP-1 analogue |
| SA026182 | - | 52_19 | 52 | Treatment:GLP-1 analogue |
| SA026179 | - | 52_2 | 52 | Treatment:GLP-1 analogue |
| SA026187 | - | 52_23 | 52 | Treatment:GLP-1 analogue |
| SA026186 | - | 52_25 | 52 | Treatment:GLP-1 analogue |
| SA026185 | - | 52_27 | 52 | Treatment:GLP-1 analogue |
| SA026183 | - | 52_30 | 52 | Treatment:GLP-1 analogue |
| SA026184 | - | 52_36 | 52 | Treatment:GLP-1 analogue |
| SA026188 | - | 52_37 | 52 | Treatment:GLP-1 analogue |
| SA026168 | - | 52_38 | 52 | Treatment:GLP-1 analogue |
| SA026165 | - | 52_39 | 52 | Treatment:GLP-1 analogue |
| SA026173 | - | 52_43 | 52 | Treatment:GLP-1 analogue |
| SA026171 | - | 52_44 | 52 | Treatment:GLP-1 analogue |
| SA026172 | - | 52_45 | 52 | Treatment:GLP-1 analogue |
| SA026170 | - | 52_47 | 52 | Treatment:GLP-1 analogue |
| SA026169 | - | 52_48 | 52 | Treatment:GLP-1 analogue |
| SA026180 | - | 52_5 | 52 | Treatment:GLP-1 analogue |
| SA026167 | - | 52_52 | 52 | Treatment:GLP-1 analogue |
| SA026166 | - | 52_57 | 52 | Treatment:GLP-1 analogue |
| SA026178 | - | 52_9 | 52 | Treatment:GLP-1 analogue |
| SA026015 | - | -8_1 | -8 | Treatment:Control |
| SA026016 | - | -8_11 | -8 | Treatment:Control |
| SA026018 | - | -8_12 | -8 | Treatment:Control |
| SA026020 | - | -8_15 | -8 | Treatment:Control |
| SA026009 | - | -8_20 | -8 | Treatment:Control |
| SA026010 | - | -8_21 | -8 | Treatment:Control |
| SA026000 | - | -8_22 | -8 | Treatment:Control |
| SA025998 | - | -8_24 | -8 | Treatment:Control |
| SA025996 | - | -8_26 | -8 | Treatment:Control |
| SA026001 | - | -8_28 | -8 | Treatment:Control |
| SA026003 | - | -8_29 | -8 | Treatment:Control |
| SA026014 | - | -8_3 | -8 | Treatment:Control |
| SA026007 | - | -8_34 | -8 | Treatment:Control |
| SA026006 | - | -8_35 | -8 | Treatment:Control |
| SA026002 | - | -8_40 | -8 | Treatment:Control |
| SA026005 | - | -8_41 | -8 | Treatment:Control |
| SA026004 | - | -8_42 | -8 | Treatment:Control |
| SA026008 | - | -8_46 | -8 | Treatment:Control |
| SA025997 | - | -8_49 | -8 | Treatment:Control |
| SA025999 | - | -8_51 | -8 | Treatment:Control |
| SA026019 | - | -8_54 | -8 | Treatment:Control |
| SA026017 | - | -8_58 | -8 | Treatment:Control |
| SA026013 | - | -8_6 | -8 | Treatment:Control |
| SA026011 | - | -8_7 | -8 | Treatment:Control |
| SA026012 | - | -8_8 | -8 | Treatment:Control |
| SA026039 | - | -8_10 | -8 | Treatment:GLP-1 analogue |
| SA026033 | - | -8_14 | -8 | Treatment:GLP-1 analogue |
| SA026030 | - | -8_17 | -8 | Treatment:GLP-1 analogue |
| SA026031 | - | -8_19 | -8 | Treatment:GLP-1 analogue |
| SA026034 | - | -8_2 | -8 | Treatment:GLP-1 analogue |
| SA026032 | - | -8_23 | -8 | Treatment:GLP-1 analogue |
| SA026038 | - | -8_25 | -8 | Treatment:GLP-1 analogue |
| SA026042 | - | -8_27 | -8 | Treatment:GLP-1 analogue |
| SA026046 | - | -8_30 | -8 | Treatment:GLP-1 analogue |
| SA026045 | - | -8_31 | -8 | Treatment:GLP-1 analogue |
| SA026043 | - | -8_33 | -8 | Treatment:GLP-1 analogue |
| SA026040 | - | -8_36 | -8 | Treatment:GLP-1 analogue |
| SA026041 | - | -8_37 | -8 | Treatment:GLP-1 analogue |
| SA026044 | - | -8_38 | -8 | Treatment:GLP-1 analogue |
| SA026035 | - | -8_39 | -8 | Treatment:GLP-1 analogue |
| SA026022 | - | -8_43 | -8 | Treatment:GLP-1 analogue |
| SA026021 | - | -8_44 | -8 | Treatment:GLP-1 analogue |
| SA026027 | - | -8_45 | -8 | Treatment:GLP-1 analogue |
| SA026026 | - | -8_47 | -8 | Treatment:GLP-1 analogue |
| SA026029 | - | -8_48 | -8 | Treatment:GLP-1 analogue |
| SA026036 | - | -8_5 | -8 | Treatment:GLP-1 analogue |
| SA026024 | - | -8_50 | -8 | Treatment:GLP-1 analogue |
| SA026025 | - | -8_52 | -8 | Treatment:GLP-1 analogue |
| SA026023 | - | -8_53 | -8 | Treatment:GLP-1 analogue |
| SA026028 | - | -8_57 | -8 | Treatment:GLP-1 analogue |
| SA026037 | - | -8_9 | -8 | Treatment:GLP-1 analogue |
| SA026066 | - | 0_1 | - | Treatment:Control |
| SA026069 | - | 0_11 | - | Treatment:Control |
| SA026070 | - | 0_12 | - | Treatment:Control |
| SA026071 | - | 0_15 | - | Treatment:Control |
| SA026050 | - | 0_20 | - | Treatment:Control |
| SA026049 | - | 0_21 | - | Treatment:Control |
| SA026052 | - | 0_22 | - | Treatment:Control |
| SA026048 | - | 0_24 | - | Treatment:Control |
| SA026051 | - | 0_26 | - | Treatment:Control |
| SA026059 | - | 0_28 | - | Treatment:Control |
| SA026058 | - | 0_29 | - | Treatment:Control |
| SA026064 | - | 0_3 | - | Treatment:Control |
| SA026053 | - | 0_34 | - | Treatment:Control |
| SA026056 | - | 0_35 | - | Treatment:Control |
| SA026065 | - | 0_40 | - | Treatment:Control |
| SA026055 | - | 0_41 | - | Treatment:Control |
| SA026054 | - | 0_42 | - | Treatment:Control |
| SA026057 | - | 0_46 | - | Treatment:Control |
| SA026047 | - | 0_49 | - | Treatment:Control |
| SA026067 | - | 0_51 | - | Treatment:Control |
| SA026060 | - | 0_54 | - | Treatment:Control |
| SA026063 | - | 0_58 | - | Treatment:Control |
| SA026061 | - | 0_6 | - | Treatment:Control |
| SA026062 | - | 0_7 | - | Treatment:Control |
| SA026068 | - | 0_8 | - | Treatment:Control |
| SA026090 | - | 0_10 | - | Treatment:GLP-1 analogue |
| SA026084 | - | 0_14 | - | Treatment:GLP-1 analogue |
| SA026081 | - | 0_16 | - | Treatment:GLP-1 analogue |
| SA026082 | - | 0_17 | - | Treatment:GLP-1 analogue |
| SA026083 | - | 0_19 | - | Treatment:GLP-1 analogue |
| SA026087 | - | 0_2 | - | Treatment:GLP-1 analogue |
| SA026089 | - | 0_23 | - | Treatment:GLP-1 analogue |
| SA026092 | - | 0_25 | - | Treatment:GLP-1 analogue |
| SA026096 | - | 0_27 | - | Treatment:GLP-1 analogue |
| SA026097 | - | 0_30 | - | Treatment:GLP-1 analogue |
| SA026098 | - | 0_31 | - | Treatment:GLP-1 analogue |
| SA026094 | - | 0_33 | - | Treatment:GLP-1 analogue |
| SA026095 | - | 0_36 | - | Treatment:GLP-1 analogue |
| SA026091 | - | 0_37 | - | Treatment:GLP-1 analogue |
| SA026093 | - | 0_38 | - | Treatment:GLP-1 analogue |
| SA026086 | - | 0_39 | - | Treatment:GLP-1 analogue |
| SA026073 | - | 0_43 | - | Treatment:GLP-1 analogue |
| SA026075 | - | 0_44 | - | Treatment:GLP-1 analogue |
| SA026078 | - | 0_45 | - | Treatment:GLP-1 analogue |
| SA026079 | - | 0_47 | - | Treatment:GLP-1 analogue |
| SA026077 | - | 0_48 | - | Treatment:GLP-1 analogue |
| SA026088 | - | 0_5 | - | Treatment:GLP-1 analogue |
| SA026080 | - | 0_50 | - | Treatment:GLP-1 analogue |
| SA026074 | - | 0_52 | - | Treatment:GLP-1 analogue |
| SA026072 | - | 0_53 | - | Treatment:GLP-1 analogue |
| SA026076 | - | 0_57 | - | Treatment:GLP-1 analogue |
| SA026085 | - | 0_9 | - | Treatment:GLP-1 analogue |
